U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209940

Expand all

PREVYMIS (LETERMOVIR)
240MG/12ML (20MG/ML)
Marketing Status: Prescription
Active Ingredient: LETERMOVIR
Proprietary Name: PREVYMIS
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 240MG/12ML (20MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209940
Product Number: 001
Approval Date: Nov 8, 2017
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
PREVYMIS (LETERMOVIR)
480MG/24ML (20MG/ML)
Marketing Status: Prescription
Active Ingredient: LETERMOVIR
Proprietary Name: PREVYMIS
Dosage Form; Route of Administration: SOLUTION; INTRAVENOUS
Strength: 480MG/24ML (20MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209940
Product Number: 002
Approval Date: Nov 8, 2017
Applicant Holder Full Name: MERCK SHARP AND DOHME CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top